Natera, Inc. (NTRA)
186.36
-10.55
(-5.36%)
USD |
NASDAQ |
May 15, 16:00
193.00
+6.64
(+3.56%)
Pre-Market: 20:00
Natera EPS Diluted (Quarterly) : -0.6013 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0012 |
| Illumina, Inc. | 0.8701 |
| Mettler-Toledo International, Inc. | 8.332 |
| Guardant Health, Inc. | -0.8538 |
| GeneDx Holdings Corp. | -2.158 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -85.09M |
| Revenue (Quarterly) | 696.64M |
| Total Expenses (Quarterly) | 781.74M |
| Enterprise Value | 25.84B |
| Gross Profit Margin (Quarterly) | 63.90% |
| Profit Margin (Quarterly) | -12.21% |
| Earnings Yield | -0.88% |
| Normalized Earnings Yield | -0.8702 |